Infusion Pumps Market Growing at a CAGR of 6.0% During 2016 to 2021

The infusion pumps market is estimated to grow at a CAGR of 6.0% from 2016 to 2021, to reach USD 10.84 billion by 2021 from USD 8.12 billion in 2016 while the Asia-Pacific market is expected to register the highest CAGR during the forecast period.

Increasing prevalence of chronic diseases along with increasing geriatric population, increasing adoption of portable infusion pumps to reduce hospital expenditure, steady increase in surgical procedural volumes, and rising applications of infusion pumps in pain management are some of the key factors driving the growth of this market. However, patient safety risks and medication errors associated with infusion pumps leading to product recalls and stringent regulations for new products may restrict the growth of this market during the forecast period.

Browse 238 tables and 48 figures, 11 Company profiles spread across 294 pages available at .

On the basis of product type, the infusion pumps market is segmented into devices and accessories. The Accessories segment is further segmented into dedicated and non-dedicated disposables. The dedicated disposables segment accounted for the largest share of the infusion pump accessories market in 2015. Devices segment is further sub segmented into volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, entreat infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps. In 2015, the volumetric infusion pumps segment dominated the infusion pump devices market. The large share of this segment can be attributed to the increasing demand for volumetric infusion pumps in hospitals, long-term acute care centers, clinics, and ambulatory surgery centers.

Some of the major market players in the global infusion pumps market include Becton, Dickinson and Company (U.S.), Baxter International, Inc. (U.S.), Pfizer Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius SE & CO. KGaA (Germany), Medtronic plc (Ireland), Smiths Group plc (U.K.), Terumo Corporation (Japan), Moog, Inc. (U.S.), F. Hoffmann-la Roche Ltd.(Switzerland), and Johnson & Johnson (U.S.). Order a copy of Infusion Pump Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA, Accessories), Application (Oncology, Diabetes, Gastroenterology, Analgesia, Pediatrics, Hematology) & End User (Hospital, Home care) - Global Forecast to 2021 research report at .

North America represented the largest infusion pump market in 2015, followed by Europe and Asia-Pacific. The Asia-Pacific market is expected to register the highest CAGR during the forecast period. Factors such as large population, increasing geriatric population, growing incidence of chronic diseases, rising awareness and accessibility of advanced healthcare facilities, rising healthcare spending, rapidly improving health insurance sector, growing demand for advanced technologies, and expansion of private-sector hospitals to rural areas are fueling the demand for infusion devices in the APAC region.

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsanRreports
Address: 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune – 411013. Maharashtra, India.
Phone: + 1 888 391 5441

Release ID: 173374